Insider Trading activities of Decode Genetics Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Decode Genetics Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Decode Genetics Inc since year 2005. Table 2 shows the detailed insider transactions of Decode Genetics Inc since 2005. The reporting company's ticker symbol is DCGN. The reporting company's CIK number is 1022974.
The total value of stock buying since 2005 is $3,280.
The total value of stock sales since 2005 is $49,961.
The total value of stock option exercises since 2005 is $0.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Decode Genetics Inc (DCGN).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2008-09 0 $0 1,871 $1,216 0 $0
2007-06 1,000 $3,280 0 $0 0 $0
2005-08 0 $0 5,000 $48,745 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Decode Genetics Inc insiders (DCGN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-09-16 Sigurdsson Jakob O (S.V.P., Corporate Development) Sale 1,871 .65 1,216
2007-06-05 Gurney Mark (Sr. VP Drug Discovery & Dvpmt) Buy 1,000 3.28 3,280
2005-08-24 Hakonarson Hakon (V.P., Clinical Studi) Sale 5,000 9.75 48,745

Insider trading activities including stock purchases, stock sales, and option exercises of DCGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Decode Genetics Inc (symbol DCGN, CIK number 1022974) see the Securities and Exchange Commission (SEC) website.